APA

Léveillé N., Elkon R., Davalos V., Manoharan V., Hollingworth D., Oude Vrielink J., le Sage C., Melo C. A., Horlings H. M., Wesseling J., Ule J., Esteller M., Ramos A. & Agami R. (20120118). Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. : Nature communications.

Chicago

Léveillé Nicolas, Elkon Ran, Davalos Veronica, Manoharan Vijayalaxmi, Hollingworth Dave, Oude Vrielink Joachim, le Sage Carlos, Melo Carlos A, Horlings Hugo M, Wesseling Jelle, Ule Jernej, Esteller Manel, Ramos Andres and Agami Reuven. 20120118. Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. : Nature communications.

Harvard

Léveillé N., Elkon R., Davalos V., Manoharan V., Hollingworth D., Oude Vrielink J., le Sage C., Melo C. A., Horlings H. M., Wesseling J., Ule J., Esteller M., Ramos A. and Agami R. (20120118). Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. : Nature communications.

MLA

Léveillé Nicolas, Elkon Ran, Davalos Veronica, Manoharan Vijayalaxmi, Hollingworth Dave, Oude Vrielink Joachim, le Sage Carlos, Melo Carlos A, Horlings Hugo M, Wesseling Jelle, Ule Jernej, Esteller Manel, Ramos Andres and Agami Reuven. Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. : Nature communications. 20120118.